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3Abstract39
Background/objectives: Vitamin C intake has been inversely associated with breast40
cancer risk in case-control studies, but not in meta-analyses of cohort studies using41
Food Frequency Questionnaires, which can over-report fruit and vegetable intake, the42
main source of vitamin C. This is the first study to investigate associations between43
vitamin C intake and breast cancer risk using food diaries.44
Subjects/Methods: Estimated dietary vitamin C intake was derived from four to seven45
day food diaries pooled from five prospective studies in the UK Dietary Cohort46
Consortium. This nested case-control study of 707 incident breast cancer cases and47
2144 matched controls examined breast cancer risk in relation to dietary vitamin C48
intake using conditional logistic regression adjusting for relevant covariates.49
Additionally, total vitamin C intake from supplements and diet was analysed in three50
cohorts.51
Results: No evidence of associations were observed between breast cancer risk and52
vitamin C intake analysed for dietary vitamin C intake (OR = 0.98 per 60mg/d, 95%CI:53
0.88 to 1.09, Ptrend = 0.7), dietary vitamin C density (OR = 0.97 per 60mg/d, 95% CI:54
0.87 to 1.07) or total vitamin C intake (OR = 1.01 per 60mg/d, 95%CI: 0.99 to 1.03,55
Ptrend = 0.3). Additionally, there was no significant association for post-menopausal56
women (OR = 1.02 per 60mg/d, 95%CI: 0.99 to 1.05, Ptrend = 0.3).57
Conclusions: This pooled analysis of individual UK women found no evidence of58
significant associations between breast cancer incidence and dietary or total vitamin C59
intake derived uniquely from detailed diary recordings.60
Key Words: Breast cancer, Vitamin C, cohort studies, food diaries.61
4Introduction62
In the UK a woman's cumulative risk of being diagnosed with breast cancer is 6% by63
the age of 65, and 11% over a lifetime (Office for National Statistics 2000). It has been64
hypothesised that antioxidant properties of vitamin C can reduce cancer risk by65
decreasing reactive oxygen species (ROS) that may cause DNA damage (Willcox et al66
2004). ROS, nevertheless, are involved in apoptosis, the beneficial death of tumour67
cells (Valko et al 2006).68
Initial findings from retrospective case-control studies showed that fruit and vegetable69
intake, the main source of vitamin C, and also vitamin C intake were inversely70
associated with breast cancer risk (Gandini et al 2000, WCRF/AICR 1997,71
WCRF/AICR 2007). However, no conclusive evidence of a protective effect from fruit72
and vegetables has been produced prospectively from cohort studies (Key 2010,73
Michels et al 2007, Smith-Warner et al 2001, van Gils et al 2005, WCRF/AICR 2007).74
Similarly, the meta-analyses of prospective cohorts using Food Frequency75
Questionnaires (FFQs) in the 2007 World Cancer Research Fund (WCRF) report76
showed no significant associations with dietary or supplement vitamin C intake, nor in77
subgroup analyses by menopausal status (WCRF/AICR 2007). Only four prospective78
studies in this report included vitamin C from supplements as well as diet (Cho et al79
2003, Kushi et al 1996, Nissen et al 2003, Zhang et al 1999), one of which showed an80
increased risk with increased total vitamin C intake (Nissen et al 2003). Only two81
studies since the WCRF report was published have assessed total vitamin C intake82
and breast cancer risk,(Cui et al 2008, Roswall et al 2010), one of which found a weak83
positive association (Cui et al 2008).84
FFQs tend to encourage the over-reporting of fruit and vegetable consumption85
(Bingham et al 1997, Cade et al 2002, Calvert et al 1997), leading to the over-86
estimation of vitamin C intake (Bingham et al 1997). Alternatively, diaries may more87
5accurately record numbers of fruit and vegetable portions consumed individually or in88
mixed dishes, (Bingham et al 1997) over a period of days, though they are limited by89
their short-term nature.90
Our pooled analysis of the UK Dietary Cohort Consortium is the first study to91
investigate the relationship between breast cancer risk and vitamin C intake using food92
diaries; an alternative tool to FFQs used in previous analyses. Additionally, the current93
analysis is one of a small number of prospective studies assessing the relationship of94
breast cancer risk with total vitamin C intake, which includes intake from supplements95
as well as from diet.96
97
Methods98
Subjects99
Individual participant data were pooled from five established cohort studies within the100
UK Dietary Cohort Consortium: EPIC-Norfolk (Bingham et al 2001) the UK Women’s101
Cohort Study (UKWCS) (Cade et al 2004), EPIC-Oxford (Davey et al 2003), Whitehall102
II (Marmot and Brunner 2005), and the MRC National Survey of Health and103
Development (NSHD) (Wadsworth et al 2006). Methods used were similar to those104
previously described for colorectal case-control analyses nested within this UK105
consortium(Dahm et al 2010).106
Case ascertainment and matching107
Incident cases of breast cancer were identified from data provided by UK cancer108
registries based on the International Classification of Diseases (ICD) version 9 (174) or109
10 (C50). Diagnoses within six months of food diary completion were excluded to110
ensure that latent disease without formal diagnosis was not present; otherwise disease111
suspected by participants could have influenced their dietary habits. Across the cohorts112
707 incident cases and 2144 controls were used in the dietary vitamin C analysis. Only113
6three cohorts (EPIC-Oxford, EPIC-Cambridge and UKWCS) were used in the total114
vitamin C analysis which involved 601 incident cases and 1725controls (85% of the115
consortium participants); the remaining two cohorts did not have adequate supplement116
use data to determine the vitamin C content of supplements consumed at diary date.117
Within each cohort, each case was matched to randomly selected controls based on118
age at recruitment (± 3 years) and date of diary completion (± 3 months or as close as119
possible). The number of controls matched to cases was four for EPIC-Norfolk,120
Whitehall and NSHD, and up to five for UKWCS. In EPIC-Oxford one control was121
matched to each case, to within six months of case diary completion. Controls had no122
registry-reported cancer diagnosis at recruitment (except non-melanoma skin cancer)123
and were free from breast cancer at the end of the follow-up period. The mean length124
of follow-up for cases in the cohorts ranged from 2.4 years to 10.8 years as detailed in125
Table 1; these were not adjusted for in the analyses.126
Insert Table 1127
Dietary methods128
All cohorts collected dietary information using semi-weighed food diaries or129
photographs to aid the estimation of portion size. The number of days intake recorded130
for each cohort is shown in table 1.131
Food diary details were input by trained food diary analysts; the majority were entered132
into Data into Nutrients for Epidemiological Research (DINER), and checked and133
calculated using DINERMO to derive nutrient data (Welch et al 2001). Diaries from134
UKWCS were entered using an in-house Microsoft Access-based dietary analysis135
program (DANTE), which had previously been validated against DINER on a136
subsample of 100 randomly selected diaries, with acceptable agreement (Dahm et al137
2010). Diaries from the NSHD were entered into DIDO (Price et al 1995); which, after138
7validation proved to use portion sizes and recipes that were more concurrent with the139
time of NSHD diary completion. All estimated dietary vitamin C intake was based on140
standard tables of food composition and daily averages were calculated (Holland et al141
1991).142
In separate sections of the diaries, participants were asked to record supplement143
brand, name and amount per day for any supplement taken. In three cohorts144
databases were created to match this information against manufacturers’ information:145
EPIC-Norfolk (Lentjes et al 2011) and EPIC-Oxford and UKWCS (Hutchison et al146
2011). The two databases included supplement descriptions and ingredient147
composition from product labels directly obtained from manufacturers or the148
participants' descriptions and/or labels. Where participants were unclear in their149
description, a weighted average of vitamin C from similar supplements was calculated150
from the database and applied (Lentjes et al 2011). For instance, separate generic151
averages were calculated for multivitamins, antioxidant ACE supplements and high152
dose vitamin C supplements. For each participant the average daily vitamin C amount153
consumed from all supplement types was calculated.154
Statistical methods155
Separate quintile cut points were determined for dietary intake (mg per day), dietary156
vitamin C intake density (mg per megajoule per day) and total vitamin C intake157
including supplements (mg per day). Dietary vitamin C intake density was analysed as158
a separate method of controlling for potential confounding by total energy intake.159
Conditional logistic regression was used to model the associations between fifths of160
vitamin C intake and breast cancer incidence. To test for linear trends we used161
continuous intake variables per increment of approximately one standard deviation of162
mean intake (being 60mg/day for dietary intake and 8mg/MJ/day for intake density). No163
8supplement intakes were implausible. However, in sensitivity analyses women with164
extreme intakes, defined as more than 1.5 times the inter-quartile range above the 75th165
percentile, were excluded in tests for linear trends. These upper thresholds were 224.1166
mg/d for dietary intake, 30.6 mg/MJ/day for intake density and 262.4 mg/d for total167
vitamin C intake, which excluded 77, 91 and 206 women respectively.168
Due to the process of matching cases and controls the conditional logistic regression169
model automatically adjusted for date of diary completion, age (in years) and cohort.170
The multivariate model adjusted for exact age, parity (0, 1, 2, 3, 4+, missing), hormone171
replacement therapy use (current, non-current, missing), alcohol intake, total energy172
intake, weight (<60kg, 60-, 66-, >72kg, missing), height (<158cm, 158-, 163-, >168cm,173
missing), physical activity (low, low-medium, medium-high, high, missing), and174
menopausal status (pre, peri or post-menopausal, missing). The level of missing data175
ranged from 0% for alcohol and total energy intake, to 0.4% for parity to 3.6% for176
physical activity. Alcohol and total energy intake were ascertained from the diaries. All177
other covariates were collected by standard questionnaires, either self-administered or178
by trained researchers at or close to time of diary completion. Sensitivity analysis was179
performed to adjust for variables which have weaker associations with breast cancer180
risk; smoking status and level of education, and also to adjust for important risk181
variables which had moderate levels of missing data; age at menarche (16%) and182
cumulative duration of breastfeeding (weeks) (18%); which restricted the sensitivity183
analysis to 2150 participants. To investigate robustness of results to missing data,184
analyses were repeated using multiple imputation by chained equations (Royston185
2009), with imputations based on exposure, covariates and outcome. Additional186
sensitivity analyses also controlled for dietary vitamin E and iron which affect vitamin C187
bioavailability. Finally, we formally tested our assumption of no heterogeneity across188
the different cohorts by including an exposure by centre interaction term in the models.189
9Analyses were carried out using Stata version 10 and results were based on a190
significance level of p<0.05.191
Results192
Dietary vitamin C intake193
On average the total women (2851) in the five cohorts were 56 years old and194
consumed 346g/d fruit and vegetables; 65% were post-menopausal, 58% had never195
smoked, 17% were educated to degree, HNC or HND level, and only 18% took HRT at196
the date of diary completion.197
As observed in table 2 total cases (707) had similar characteristics to the 2144 controls198
and their mean (sd) dietary vitamin C intakes were 98mg/d (56) and 95mg/d (52)199
respectively. Women with a higher dietary vitamin C intake tended to have a higher200
energy intake, consume more alcohol, dietary vitamin E and iron as well as more fruit201
and vegetables. Additionally they had fewer children, were more active, had attained202
higher levels of education, or were more likely to be of higher socio-economic status or203
to have never smoked (table 2)204
Insert Table 2205
The odds ratios for breast cancer according to dietary intake of vitamin C in the five206
cohorts are shown in table 3 for the unadjusted and multivariable model. There was no207
evidence of any significant association between dietary vitamin C intake and incidence208
of breast cancer for total women in the five cohorts. In the adjusted analysis for total209
women the odds ratio of breast cancer per 60mg/day increments was 0.98 (95%CI:210
0.88 to 1.09, Ptrend = 0.7) Similarly, there was no evidence of any linear trends or211
significant associations between dietary vitamin C intake groups and incidence of212
breast cancer in the sub-analysis by post-menopausal status (OR=0.98 per 60mg/day,213
10
95%CI: 0.85 to 1.13, Ptrend = 0.8). The results remained non-significant in sensitivity214
analyses after further adjustment for smoking status, age at menarche, cumulative215
duration of breastfeeding (weeks), and level of education. Odds ratios did not alter216
substantially. There was no evidence of any linear trends or significant association217
between the incidence of breast cancer and dietary vitamin C expressed as intake218
density (Table 4). In the sensitivity analyses, which excluded women with extreme219
dietary vitamin C intakes, the odds ratios for linear trends relating to absolute dietary220
intake and intake density were reduced to between 0.91 and 0.95 but none were221
statistically significant.222
Insert table 3 and 4223
In tests for heterogeneity there was evidence of differences between the five study224
centres when a study centre by dietary vitamin C intake group interaction term was225
included (p=0.10 total women; p=0.05 post-menopausal).226
The mean (sd) dietary intake by cohort are shown in Table 1 The lower intake for the227
younger, nationally representative NSHD women (mean age 43 vs 50s in other228
cohorts) reflected previous findings from households with similar aged adults (Defra229
2004).230
Total vitamin C intake231
In the analyses of total vitamin C cases had a somewhat higher total vitamin C intake232
than controls: 174mg/d (sd 374) vs 143mg/d (sd 213). The average vitamin C intake233
from supplements for cases was 1.5 times higher than controls: 73mg/d (sd 364) vs234
48mg/d (sd 201). Total intakes by cohort are shown in table 1. The mean vitamin C235
supplement intake per day for EPIC-Norfolk was significantly less than for UKWCS and236
EPIC-Oxford Based on diary completion date, mean total intake in autumn and winter237
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compared to spring and summer was not significantly different (151.7. (sd 312) vs238
151.4 (sd 218) mg/d); comprising respectively of 46.4.1% and 53.6% of these women.239
The relationships between total vitamin C intake split by fifths and lifestyle240
characteristics were similar to those for dietary only intake shown in table 2. The241
highest intake group had the highest vitamin C intake from both diet and supplements242
(mean (sd) 159 (69) mg/d) and 256 (519) mg/d respectively); in this group 62% took243
supplements containing vitamin C and 84% of these women took them every day.244
In pooling the three cohorts which recorded vitamin C intake from supplements there245
was also no evidence of any significant associations between total vitamin C intake and246
incidence of breast cancer for the continuous estimate for all women (OR = 1.01 per247
60mg/d, 95%CI: 0.99 to 1.03, Ptrend = 0.3), or for post-menopausal women (OR = 1.02248
per 60mg/d, 95%CI: 0.99 to 1.05, Ptrend = 0.3) or by fifths of total vitamin C intake (table249
5). There was no evidence of significant differences between the three study centres250
when formally tested using a study centre by fifths of total vitamin C intake interaction251
term, for total and for post-menopausal women (p=0.7 and p=0.7 respectively).252
For both dietary and total intake no substantial differences in the estimates were found253
in sensitivity analyses controlling for dietary vitamin E and iron.254
Finally, a total of 73 matched case-control sets in the main analyses had some missing255
covariate information, mostly in HRT exposure, however the strength of associations256
were almost identical whether these matched sets were included by using a category257
for missing, or included with additional information using multiple imputation.258
Insert table 5259
260
261
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Discussion262
This pooled analysis of individual participant data from five UK cohorts found no263
evidence of an association between incidence of breast cancer and dietary vitamin C264
intake recorded by food diaries. Neither was there any evidence of an association with265
total vitamin C intake when vitamin C from supplements was included. Our non-266
significant results for post-menopausal women relating to dietary vitamin C intake267
support results of the 2007 WCRF meta-analyses of three cohort studies (HR=1.15 per268
100mg/d, 95% CI: 0.92-1.43) (Graham et al 1992, Nissen et al 2003, Verhoeven et al269
1997, WCRF/AICR 2007), also the high versus low intake results of two US studies270
(Kushi et al 1996, Zhang et al 1999), and the recent European Prospective271
Investigation into Cancer (EPIC) involving the pooling of data from 10 European272
countries (highest vs. lowest quintile HR = 0.98, 95% CI: 0.87–1.11) (Nagel et al 2010);273
all of which used FFQs. Our results for dietary vitamin C are in conflict with significant274
evidence of a 12-14% reduced risk found in the meta-analysis of retrospective case-275
control studies (WCRF/AICR 2007) which, unlike our study, are prone to recall bias.276
In contrast to our results and other studies (Cho et al 2003, Kushi et al 1996, Roswall277
et al 2010, Zhang et al 1999), the large Women’s Health Initiative study (Cui et al 2008)278
found significant but weak evidence of increased breast cancer risk for total intake. The279
advanced age of the participants in this cohort (average 64 years) might suggest that280
high vitamin C intake may promote the progression of cancer in older people or at later281
stages of the disease. Similarly positive associations with post-menopausal breast282
cancer for both dietary and total vitamin C intake (OR= 2.06 per 100mg/d, 95% CI:283
1.45-2.91; and OR=1.08 per 100mg/d, 95% CI: 1.02-0.1.15 respectively) were found in284
a small Danish nested case-control study (Nissen et al 2003), but not in the recent full285
analysis of this Danish cohort (Roswall et al 2010); selection bias of controls or286
exclusion of non-supplement users may have possibly influenced the earlier results.287
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288
Pooling individual participant data in this consortium had three advantages. Firstly, it289
ensured that vitamin C intake over the whole consortium could be categorised into290
fifths; secondly the variations in intake across the cohorts increase the power to detect291
smaller effect sizes (Schatzkin et al 2001), i.e. many women in EPIC-Oxford and292
UKWCS were vegetarians and/ or consumed supplements containing vitamin C293
compared to the other cohorts; thirdly, analysis and adjustment by covariates could be294
done in a uniform way.295
Our study had a few caveats. Whilst the use of missing covariate categories may have296
grouped dissimilar individuals and introduced some bias, its affect on the adjusted297
results may be considered acceptable since the level of missing data was small,298
confounding was judged to be weak and multiple imputation results were almost299
identical. To account for the possible modulation of vitamin C on cancer development300
due to its the role in the regeneration of vitamin E, in the absorption of iron and in the301
Fenton reaction, (Valko et al 2006) sensitivity analysis adjustments were made for302
these dietary nutrients. Supplement intake data for these nutrients, however, was not303
available. The Danish studies, one of which found a positive association, controlled for304
both dietary and supplement intake of vitamin A and E (Nissen et al 2003, Roswall et al305
2010). In the current study data were unavailable to adjust for family history of breast306
cancer which has been associated with high-dose vitamin C supplement use in the UK307
(Hutchinson et al 2011). Data were unavailable from all cohorts to exclude general308
supplement users from the dietary analysis; the different health behaviours of users309
may have influenced the results (Kirk et al 1999). There was inadequate power to sub-310
analyse by HRT users, oestrogen receptor-negative or pre-menopausal breast311
cancers.312
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This is the first time the relationship between breast cancer risk and vitamin C intake313
has been analysed using prospective data from food diaries. Diaries can capture314
detailed and accurate intake over a narrow period of days due to their open format,315
whereas FFQs aim to reflect intake over a much longer period, normally an estimated316
average of the previous 12 months. Repeated diary data collections may reduce their317
short-term limitations but were not undertaken for the whole consortium due to expense318
and time taken to administer, complete and analyse. The required commitment and319
awareness of intake may have also influence participants’ consumption during diary320
recording. When compared to FFQs, food diaries have shown stronger correlations321
with plasma vitamin C biomarkers in validity tests when collected in close temporal322
proximity. However this may reflect the short-term nature of both plasma vitamin C and323
diary data, particularly since correlations with biomarker levels re-measured several324
years later were similar for diaries and FFQs (Bingham et al 2008, Bingham et al 1997,325
Willett 2008) Furthermore, other UK validation studies have shown similar associations326
between biomarkers and vitamin C estimated from FFQs and diaries (Brunner et al327
2001, Michels et al 2005). Overall correlations between biomarkers and FFQs or328
diaries are generally weak to moderate (Cade et al 2002, Henríquez-Sánchez et al329
2009). Since the absorption and storage of vitamin C is limited, particularly above330
400mg/d (Levine et al 2001), biomarkers are unlikely to reflect dietary vitamin C intake331
well. Therefore it is difficult to objectively assess whether diaries or FFQs can rank332
individual intake sufficiently well in order to find associations between vitamin C and333
cancer risk. Given the limitations, vitamin C results from both FFQs and diaries need to334
be treated with some caution.335
To conclude, the evidence to date from this and other prospective studies does not336
indicate either a beneficial or a detrimental effect of vitamin C intake on breast cancer337
risk, whether this intake is from diet only or also from supplements.338
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Table 1: Characteristics of the 5 cohorts participating in analyses of vitamin C and breast cancer risk in the UK Dietary Cohort Consortium.
Cohort Participants Diary
days
Years when
food diary
completed
Last
follow up
date
Mean
time to
diagnosis
of cases
Cases Controls Mean(sd)
dietary
vit c
intake
Mean(sd)
total
vit c
intake
EPIC-Norfolk General population in
Norfolk
7 days 1993-1998 31.12.2006 6.0 yrs 365 1329 91 (50) 118 (167)
EPIC-Oxford General population and
vegetarians in the UK
7 days 1993-1998 31.12.2004 3.5 yrs 194 194 111 (61) 233 (436)
UK Women’s
Cohort Study
(UKWCS)
Middle aged women in
the UK
4 days 1999-2003 31.12.2006 2.4 yrs 42 202 118 (60) 251 (376)
Whitehall II Civil servants in the UK 7 days 1991-1993 30.09.2005 7.8 yrs 70 275 101 (51) _a
National
Survey of
Health and
Development
(NSHD)
Nationally reprehensive
cohort of women who
were born in one week
in March 1946 in
England, Wales and
Scotland.
5 days 1989 31.12.2006 10.8 yrs 36 144 66 (37) _a
aWhitehall and NSHD did not have detailed diary data of vitamin C intake from supplements
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Table 2: Participant characteristics by fifth of dietary vitamin C intake derived from food diaries in the UK Dietary Cohort Consortium
Breast cancer Dietary vitamin C intake (diary fifths)
Covariates (at diary date) Cases Controls 1 2 3 4 5 P*
Cases/controls 707 2144 130/440 138/432 144/426 142/428 153/418
Dietary vitamin C intake (mg/day) mean (SD) 98 (56) 95 (52) 36.9 (9.9) 61.9 (6.4) 85.1 (7.2) 114.6 (10.0) 178.4(45.5)
Fruit Intake g/d mean (SD) 191 (138) 185 (135) 81 (74) 136 (84) 188 (105) 223 (123) 304 (159) <0.001
Vegetable intake g/d mean (SD) 165 (86) 158 (82) 101 (49) 141 (59) 161 (65) 182 (79) 214 (104) <0.001
Age at diary completion (yr) mean (SD) 55.7 (9.4) 56.3 (9.6) 55.5 (10.0) 55.7 (9.8) 56.9 (9.6) 56.8 (9.6) 56.0 (9.4) 0.3
Height (cm) mean (SD) 163 (7) 162 (6) 160.7 (6.5) 161.5 (6.3) 161.8 (6.8) 162.3 (6.4) 162.9 (6.2) <0.001
Weight (kg) mean (SD) 67.8 (11.8) 67.2 (12.2) 67.9 (12.0) 67.5 (12.6) 67.8 (12.7) 66.6 (11.2) 66.8 (12.0) 0.1
Energy intake (diary, MJ/day) mean (SD) 7.6 (1.7) 7.4 (1.7) 6.8 (1.8) 7.4 (1.6) 7.4 (1.6) 7.7 (1.7) 7.8 (1.7) <0.001
Alcohol intake (diary, g/day) mean (SD) 10.3 (13.6) 8.7 (12.8) 7.9 (12) 8.5 (13) 10.3 (14) 9.0 (13) 9.7 (13) 0.02
Total fat (g/d) mean (SD) 68.9 (21.8) 67.2 (22.0) 64.9 (21.3) 69.5 (21.7) 66.2 (21.5) 70.3 (22.5) 67.6 (21.4) 0.07
Dietary vitamin E (mg/d) mean (SD) 9.9 (4.1) 9.3 (4.0) 8.0 (3.8) 9.2 (3.7) 9.3 (3.7) 10.2 (4.2) 10.6 (4.1) <0.001
Dietary Iron (mg/d) mean (SD) 11.8 (3.5) 11.3 (3.4) 9.5 (3.1) 10.9 (2.9) 11.5 (3.4) 12.0 (3.5) 13.0 (3.5) <0.001
Parity (number of children) mean (SD) 1.8 (1.2) 1.9 (1.3) 2.1 (1.3) 1.9 (1.3) 1.9 (1.3) 1.8 (1.3) 1.6 (1.3) <0.001
Exercise ( medium - high) n (%) 242 (37) 796 (38) 162 (30) 198 (36) 208 (37) 230 (42) 240 (44) <0.001
HRT use (current user) n (%) 122 (18) 373 (18) 89 (16) 94 (17) 106 (19) 110 (20) 96 (17) 0.4
Menopausal status (post-menopausal) n (%) 436 (63) 1424 (67) 352 (63) 368 (66) 385 (68) 387 (69) 367 (65) 0.2
Never smoked n (%) 413 (60) 1233 (58) 272 (49) 316 (56) 333 (59) 349 (62) 376 (67) <0.001
Education level (degree, HNC, HND) n (%) 136 (21) 313 (15) 38 (7) 68 (13 ) 77 (15) 113 (21) 151 (28) <0.001
Social class (professional or intermediate) n (%) 238 (47) 901 (47) 187 (37) 207 (42) 232 (48) 254 (53) 259 (58) <0.001
*p is Ptrend over continuous variables, and p for χ2 tests for categorical variables 
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Table 3: Dietary vitamin C intake recorded by diaries and risk of breast cancer
in the UK Dietary Cohort Consortium breast cancer study
Dietary vitamin C intake Cases/ Unadjusted * Multivariate †
Fifths: mean mg/day (sd) Controls OR (95% CI) OR (95% CI)
Total women
1 (lowest): 36.9 (9.9) 130/440 0.94 (0.71, 1.25) 0.95 (0.71, 1.28)
2 61.9 (6.4) 138/432 1 1
3 85.1 (7.2) 144/426 1.03 (0.78, 1.36) 1.00 (0.75, 1.33)
4 114.6 (10.0) 142/428 0.98 (0.74, 1.29) 0.92 (0.69, 1.22)
5 (highest): 178.4 (45.5) 153/418 1.02 (0.77, 1.35) 0.96 (0.72, 1.27)
P trend per 60mg/d 0.9 0.7
Continuous estimate/ 60mg/d 1.01 (0.91, 1.11) 0.98 (0.88, 1.09)
Post menopausal
1 (lowest) 36.9 (9.7) 77/276 1.02 (0.70, 1.48) 1.05 (0.71, 1.55)
2 62.2 (6.5) 79/289 1 1
3 85.0 (7.2) 96/289 1.22 (0.85, 1.74) 1.19 (0.82, 1.71)
4 114.9 (10.0) 91/296 1.06 (0.74, 1.52) 0.99 (0.68, 1.44)
5 (highest) 179.0 (47.7) 93/274 1.12 (0.77, 1.61) 1.01 (0.69, 1.48)
P trend per 60mg/d 0.7 0.8
Continuous estimate/ 60mg/d 1.03 (0.90, 1.17) 0.98 (0.85,1.13)
* Conditional logistic regression on cases and controls matched by cohort, age
and date of diary completion
† As for the unadjusted model * with additional adjustment for exact age, height
(<158cm, 158-, 163-, 168+), weight (<60kg, 60-, 66-, 72+), physical activity,
parity (0,1,2,3,4+), current HRT use, menopausal status, diary-derived alcohol
consumption and total energy intake. Missing data added as a category.
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Table 4: Dietary vitamin C intake densities recorded by diaries and risk of
breast cancer in the UK Dietary Cohort Consortium breast cancer study
Vitamin C nutrient density Cases/ Unadjusted* Multivariate †
Fifths: mean mg/MJ/d (sd) Controls OR (95% CI) OR (95% CI)
Total women
1 (lowest): 5.2 (1.3) 140/430 0.98 (0.75, 1.29) 0.98 (0.74, 1.30)
2 8.5 (0.8) 143/427 1 1
3 11.6 (1.0) 139/431 0.90 (0.68, 1.18) 0.89 (0.67, 1.19)
4 15.8 (1.4) 152/418 1.05 (0.81, 1.39) 1.05 (0.79, 1.39)
5 (highest): 25.0 (7.1) 133/438 0.80 (0.60, 1.06) 0.80 (0.60, 1.08)
P trend per 8 mg/MJ/d 0.4 0.5
Continuous estimate/ 8 units 0.96 (0.87, 1.06) 0.97 (0.87, 1.07)
Post menopausal
1 (lowest): 5.3 (1.3) 76/261 0.90 (0.62, 1.30) 0.89 (0.61, 1.31)
2 8.5 (0.9) 81/272 1 1
3 11.6 (1.0) 89/293 0.95 (0.66, 1.35) 0.95 (0.66, 1.37)
4 15.7 (1.4) 106/297 1.10 (0.77, 1.56) 1.11 (0.77, 1.61)
5 (highest): 25.4 (7.5) 84/301 0.80 (0.55, 1.15) 0.80 (0.54, 1.19)
P trend per 8 mg/MJ/d 0.6 0.7
Continuous estimate/ 8 units 0.97 (0.86, 1.09) 0.97 (0.86,1.10)
* Conditional logistic regression on cases and controls matched by cohort, age
and date of diary completion
† As for the unadjusted model * with additional adjustment for exact age, height
(<158cm, 158-, 163-, 168+), weight (<60kg, 60-, 66-, 72+), physical activity,
parity (0,1,2,3,4+), current HRT use, menopausal status, alcohol consumption
and total energy intake. Missing data added as a category.
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Table 5: Total vitamin C intake from diet and supplements recorded by diaries
and risk of breast cancer in EPIC-Oxford, EPIC-Norfolk and UKWCS cohorts
Total vitamin C intake Cases/ Unadjusted* Multivariate †
Fifths: mean mg/day (sd) Controls OR (95% CI) OR (95% CI)
Total women
1 (lowest): 39.3 (10.9) 101/364 0.88 (0.64, 1.21) 0.86 (0.62, 1.20)
2 69.0 (8.0) 112/353 1 1
3 97.7 (8.9) 133/332 1.21 (0.90, 1.64) 1.22 (0.89, 1.65)
4 136.9 (14.6) 130/335 1.08 (0.79, 1.48) 1.02 (0.74, 1.40)
5 (highest): 414.2 (507.3) 125/341 0.98 (0.71, 1.34) 0.93 (0.67, 1.28)
P for trend per 60mg/d 0.3 0.3
Continuous estimate/ 60mg/d 1.01 (0.99, 1.03) 1.01 (0.99, 1.03)
Post menopausal
1 (lowest) 39.7 (10.7) 72/275 0.97 (0.67, 1.41) 0.99 (0.67, 1.47)
2 68.9 (8.0) 82/292 1 1
3 97.8 (8.9) 91/257 1.29 (0.90, 1.84) 1.38 (0.95, 1.99)
4 136.2 (14.5) 83/253 1.06 (0.72, 1.55) 0.99 (0.66, 1.47)
5 (highest) 395.3 (466.7) 78/228 1.15 (0.78, 1.67) 1.08 (0.72, 1.59)
P for trend per 60mg/d 0.2 0.3
Continuous estimate/ 60mg/d 1.02 (0.99, 1.05) 1.02 (0.99,1.05)
* Conditional logistic regression on cases and controls matched by cohort, age
and date of diary completion
† As for the unadjusted model * with additional adjustment for height (<158cm,
158-, 163-, 168+), weight (<60kg, 60-, 66-, 72+), physical activity, parity
(0,1,2,3,4+), current HRT use, menopausal status, diary-derived alcohol
consumption and total energy intake. Missing data added as a category.
